Stock listing

NASDAQ:BRVE Braveheart Bio, Inc. Stock

Home listing (NASDAQ) of Braveheart Bio, Inc.

Follow Braveheart Bio, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BRVE

$18.71 USD -0.84 (-4.3%)

Close on Oct 16, 2026

Ticker
NASDAQ:BRVE
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Braveheart Bio to Participate in Stifel Cardiometabolic Forum

Sep 16, 2026

Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Sep 8, 2026

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Sep 1, 2026

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Aug 7, 2026

Braveheart Bio Announces Pricing of Upsized Initial Public Offering

Aug 5, 2026

All Braveheart Bio, Inc. news

Financings

  • Public offering of common stock

    Sep 8, 2026

    Closed: US$439.9M in the latest tranche · US$18 a share · Goldman Sachs & Co. LLC +4

    Dealers: Goldman Sachs & Co. LLC (co-lead), Jefferies (co-lead), TD Cowen (co-lead), Stifel (co-lead), Cantor (co-lead)

    Announced Aug 6, 2026 · Closed Aug 7, 2026 · Closed Sep 8, 2026

Read by 6ix AI from the company's releases

Decks

Braveheart Bio, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
5 in the last 12 months · 5 in all · newest Sep 16, 2026 · oldest 2026
Decks
2 decks · latest May 11, 2026

Where Braveheart Bio, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BRVE · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BRVEBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Braveheart Bio, Inc.